Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 1/2 3 Phase EARLY_PHASE1 1 Phase 3 1 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 108 Ovarian Neoplasms 64 Neoplasms 61 Fallopian Tube Neoplasms 40 Lung Neoplasms 37 Breast Neoplasms 33 Neoplasm Metastasis 25 Carcinoma, Ovarian Epithelial 25 Triple Negative Breast Neoplasms 21 Small Cell Lung Carcinoma 20 Esophageal Neoplasms 19 Endometrial Neoplasms 19 Colorectal Neoplasms 15 Advanced Solid Tumors 14 Squamous Cell Carcinoma of Head and Neck 13 Lymphoma, Large B-Cell, Diffuse 13 Unspecified Adult Solid Tumor, Protocol Specific 12 Stomach Neoplasms 11 Melanoma 11 Central Nervous System Neoplasms 11 Uterine Cervical Neoplasms 10 Pancreatic Neoplasms 10 Astrocytoma 10 Neuroblastoma 9 Medulloblastoma 9 Head and Neck Neoplasms 9 Carcinoma 9 Urinary Bladder Neoplasms 8 Solid Tumors 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8

Interventions

Cyclophosphamide 38 fludarabine 30 Rituximab 26 obinutuzumab 10 Bendamustine Hydrochloride 10 fludarabine phosphate 9 pembrolizumab 8 Specimen Handling 7 Etoposide 7 venetoclax 6 Vincristine 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 Leukapheresis 6 Lenalidomide 6 ibrutinib 5 Inotuzumab Ozogamicin 5 Immunotherapy, Adoptive 5 Doxorubicin 5 Biopsy 5 ublituximab 4 tazemetostat 4 glofitamab 4 Interleukin-2 4 Dexamethasone 4 Cytarabine 4 pomalidomide 3 polatuzumab vedotin 3 Radiation 3 Nivolumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Lymphoma, B-Cell × Carboplatin × Clear all

NCT01300793 2012-09-26

V-RICE

University of California, San Francisco

Phase 1 Terminated

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡